Huabo Biopharm Co., Ltd. clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-19
What changed in the last 30 days
1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
New trial filings, last 30 days
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-11-06 | NCT07920861 A Study of HB0017 Injection in Healthy Volunteers to Evaluate Safety and Tolerability of… | Phase 1 | Recruiting |
Active trials by phase
| Phase 1 | 1 | |
| Phase 1/2 | 1 | |
| Phase 2 | 1 |
Disease areas by active trials
Ankylosing Spondylitis (1) · Breast Cancer (1) · Endometrial Cancer (1) · Lung Cancer (1) · Non-Small Cell Lung Cancer (NSCLC) (1) · Psoriasis (1) · Triple-Negative Breast Cancer (1)
Get alerts when Huabo Biopharm Co., Ltd.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.